Literature DB >> 35411141

Poly(ε-Caprolactone)-Methoxypolyethylene Glycol (PCL-MPEG)-Based Micelles for Drug-Delivery: The Effect of PCL Chain Length on Blood Components, Phagocytosis, and Biodistribution.

Zemin Hou1,2, Wencheng Zhou1,2, Xi Guo2, Rui Zhong3, Ao Wang4, Jiehua Li4, Ying Cen1, Chao You2, Hong Tan4, Meng Tian2.   

Abstract

Background: The main challenge of polymeric micelles as drug delivery systems is that the actual delivery efficiency is not as high as expected, which is closely related with the interactions with the complex biological environments such as blood components, phagocytosis, and biodistribution. Herein, we expect to understand these concerns for the clinically relevant micelles that composed of methoxypolyethylene glycol (MPEG) with identical chain length And poly(ε-caprolactone) (PCL) with tunable chain length (PCLn-MPEG) (n=20, 30, and 40) wherein doxorubicin was encapsulated as a model drug.
Methods: The doxorubicin-loaded PCLn-MPEG micelles were prepared by a dialysis method and characterized by dynamic light scattering and transmission electron microscopy. The surface PEG density and chain conformation were investigated by dissipative particle dynamics simulation. The stability of the micelles was detected by nanoparticle tracking analysis. The effects of PCL chain length on the blood components, phagocytosis, and biodistribution were assayed in vitro and in vivo.
Results: The micelles exhibited spherical morphology with a diameter about 30nm. The PEG chain conformation from "mushroom-like" to "brush-like" was evident. The micelles have no remarkable effect on the red blood cells, blood coagulation, and platelet activation. Interestingly, the protein adsorption was affected and dependent on the chain conformation, with lowest adsorption for PCL30-MPEG, which also has the loWest phagocytosis. The stability of the micelles was in the order of PCL40-MPEG>PCL30-MPEG>PCL20-MPEG which was dependent on the PCL chain length. The micelles mainly accumulated in liver, with the order consistent with their stability, indicating that, besides the phagocytosis, the stability of the micelle plays an important role in biodistribution as well. The related mechanisms were proposed and discussed.
Conclusion: Manipulating the PEG/PCL ratio of the micelle is an effective approach to modulate the protein adsorption, phagocytosis, and biodistribution, which may be a prerequisite for clinical applications.
© 2022 Hou et al.

Entities:  

Keywords:  biodistribution; blood components; micelles; phagocytosis

Mesh:

Substances:

Year:  2022        PMID: 35411141      PMCID: PMC8994631          DOI: 10.2147/IJN.S349516

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  41 in total

1.  Differential uptake of nanoparticles by human M1 and M2 polarized macrophages: protein corona as a critical determinant.

Authors:  Karin A Binnemars-Postma; Hetty Wm Ten Hoopen; Gert Storm; Jai Prakash
Journal:  Nanomedicine (Lond)       Date:  2016-10-26       Impact factor: 5.307

2.  DPD studies on mixed micelles self-assembled from MPEG-PDEAEMA and MPEG-PCL for controlled doxorubicin release.

Authors:  Chufen Yang; Cong Yuan; Wenyao Liu; Jianwei Guo; Dachun Feng; Xueqiong Yin; Wenjing Lin; Peter S Shuttleworth; Hangbo Yue
Journal:  Colloids Surf B Biointerfaces       Date:  2019-02-21       Impact factor: 5.268

3.  Dense and Dynamic Polyethylene Glycol Shells Cloak Nanoparticles from Uptake by Liver Endothelial Cells for Long Blood Circulation.

Authors:  Hao Zhou; Zhiyuan Fan; Peter Y Li; Junjie Deng; Dimitrios C Arhontoulis; Christopher Y Li; Wilbur B Bowne; Hao Cheng
Journal:  ACS Nano       Date:  2018-08-23       Impact factor: 15.881

Review 4.  Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval.

Authors:  Duhyeong Hwang; Jacob D Ramsey; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2020-09-24       Impact factor: 15.470

5.  Correlation between in vitro stability and pharmacokinetics of poly(ε-caprolactone)-based micelles loaded with a photosensitizer.

Authors:  Yanna Liu; Marcel H A M Fens; Robin Bruno Capomaccio; Dora Mehn; Luca Scrivano; Robbert J Kok; Sabrina Oliveira; Wim E Hennink; Cornelus F van Nostrum
Journal:  J Control Release       Date:  2020-10-22       Impact factor: 9.776

Review 6.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Authors:  Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil
Journal:  Adv Drug Deliv Rev       Date:  2009-04-17       Impact factor: 15.470

7.  Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity.

Authors:  Wei-Jie Cheng; Shyr-Yi Lin; Michael Chen; Ling-Chun Chen; Hsiu-O Ho; Kuo-Hsiang Chuang; Ming-Thau Sheu
Journal:  Int J Nanomedicine       Date:  2021-06-10

8.  Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes.

Authors:  Yaqing Qie; Hengfeng Yuan; Christina A von Roemeling; Yuanxin Chen; Xiujie Liu; Kevin D Shih; Joshua A Knight; Han W Tun; Robert E Wharen; Wen Jiang; Betty Y S Kim
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

Review 9.  The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target.

Authors:  Lorena Baboci; Sara Capolla; Federica Di Cintio; Federico Colombo; Prisca Mauro; Michele Dal Bo; Monica Argenziano; Roberta Cavalli; Giuseppe Toffoli; Paolo Macor
Journal:  J Oncol       Date:  2020-02-24       Impact factor: 4.375

Review 10.  Biointerface engineering nanoplatforms for cancer-targeted drug delivery.

Authors:  Huaiyu Zhang; Shujun Dong; Zhongmin Li; Xiangru Feng; Weiguo Xu; Catrina Mae S Tulinao; Yang Jiang; Jianxun Ding
Journal:  Asian J Pharm Sci       Date:  2019-12-30       Impact factor: 6.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.